|
|
||||||||
Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Submitted 1 December 2004 ; accepted in final form 4 March 2005
Lung endothelial barrier function is regulated by multiple signaling pathways, including mitogen-activated protein kinases (MAPK) extracellular signal-regulated kinases (ERK) 1/2 and p38. We have recently shown involvement of microtubule (MT) disassembly in endothelial cell (EC) barrier failure. In this study, we examined potential involvement of ERK1/2 and p38 MAPK in lung EC barrier dysfunction associated with MT disassembly. MT inhibitors nocodazole (0.2 µM) and vinblastine (0.1 µM) induced sustained activation of Ras-Raf-MEK1/2-ERK1/2 and MKK3/6-p38-MAPKAPK2 MAPK cascades in human and bovine pulmonary EC, as detected by phosphospecific antibodies and in MAPK activation assays. These effects were linked to increased permeability assessed by measurements of transendothelial electrical resistance and cytoskeletal remodeling analyzed by morphometric analysis of EC monolayers. MT stabilization by taxol (5 µM, 1 h) attenuated nocodazole-induced ERK1/2 and p38 MAPK activation and phosphorylation of p38 MAPK substrate 27-kDa heat shock protein and regulatory myosin light chains, the proteins involved in actin polymerization and actomyosin contraction. Importantly, only pharmacological inhibition of p38 MAPK by SB-203580 (20 µM, 1 h) attenuated nocodazole-induced MT depolymerization, actin remodeling, and EC barrier dysfunction, whereas the MEK/ERK1/2 inhibitor U0126 (5 µM, 1 h) exhibited no effect. These data suggest a direct link between p38 MAPK activation, remodeling of MT network, and EC barrier regulation.
pulmonary endothelium; actin; extracellular signal-regulated kinases 1/2; mitogen-activated protein
This article has been cited by other articles:
![]() |
S.-Q. Xu, K. Mahadev, X. Wu, L. Fuchsel, S. Donnelly, R. G. Scalia, and B. J. Goldstein Adiponectin Protects Against Angiotensin II or Tumor Necrosis Factor {alpha}-Induced Endothelial Cell Monolayer Hyperpermeability: Role of cAMP/PKA Signaling Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 899 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Creighton, B. Zhu, M. Alexeyev, and T. Stevens Spectrin-anchored phosphodiesterase 4D4 restricts cAMP from disrupting microtubules and inducing endothelial cell gap formation J. Cell Sci., January 1, 2008; 121(1): 110 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Csortos, I. Kolosova, and A. D. Verin Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L843 - L854. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Birukova, E. Alekseeva, A. Mikaelyan, and K. G. Birukov HGF attenuates thrombin-induced endothelial permeability by Tiam1-mediated activation of the Rac pathway and by Tiam1/Rac-dependent inhibition of the Rho pathway FASEB J, September 1, 2007; 21(11): 2776 - 2786. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Singh, K. L. McCann, and F. Imani MAPK and heat shock protein 27 activation are associated with respiratory syncytial virus induction of human bronchial epithelial monolayer disruption Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L436 - L445. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Rossi, A. V. Velentza, D. M. Steinhorn, D. M. Watterson, and M. S. Wainwright MLCK210 gene knockout or kinase inhibition preserves lung function following endotoxin-induced lung injury in mice Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1327 - L1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Papaiahgari, A. Yerrapureddy, P. M. Hassoun, J. G. N. Garcia, K. G. Birukov, and S. P. Reddy EGFR-Activated Signaling and Actin Remodeling Regulate Cyclic Stretch-Induced NRF2-ARE Activation Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 304 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. V. Bogatcheva, D. Adyshev, B. Mambetsariev, N. Moldobaeva, and A. D. Verin Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L487 - L499. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nonas, I. Miller, K. Kawkitinarong, S. Chatchavalvanich, I. Gorshkova, V. N. Bochkov, N. Leitinger, V. Natarajan, J. G. N. Garcia, and K. G. Birukov Oxidized Phospholipids Reduce Vascular Leak and Inflammation in Rat Model of Acute Lung Injury Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1130 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Birukova, D. Adyshev, B. Gorshkov, G. M. Bokoch, K. G. Birukov, and A. D. Verin GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L540 - L548. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Yiming, K. Parthasarathi, A. C. Issekutz, and S. Bhattacharya Sequence of Endothelial Signaling during Lung Expansion Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 549 - 554. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |